Mesalazine Nordic

Mesalazine, the active ingredient in Mesalazine Nordic, is a 5-aminosalicylic acid (5-ASA) presented as an oral formulation for oral use. It reduces intestinal inflammation and is indicated for ulcerative colitis and colonic Crohn's disease in adult patients. GNH USA supplies Mesalazine Nordic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mesalazine Nordic belongs to the 5‑ASA class and is used to manage inflammatory bowel disease. - Ulcerative colitis: induces and maintains remission by decreasing mucosal inflammation. - Crohn's disease (colonic involvement): helps achieve symptom control and mucosal healing in patients with disease limited to the colon.

Mesalazine Nordic may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Abdominal pain or cramping: intermittent discomfort in the lower abdomen. - Flatulence: increased intestinal gas. - Rash or mild skin irritation.

Serious or Rare Side Effects: - Pancreatitis: sudden severe abdominal pain with elevated enzymes. - Severe liver injury: jaundice, elevated transaminases, or hepatic failure. - Blood dyscrasias: neutropenia, anemia, or thrombocytopenia. - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Myocarditis or pericarditis: chest pain with cardiac involvement.

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor for potential complications. - Renal function: assess baseline creatinine and monitor periodically. - Hepatic function: check liver enzymes before and during treatment. - Disease severity: ensure appropriate indication and consider alternative therapy for severe disease. - Hypersensitivity: avoid in patients with known allergy to mesalazine or related compounds. - Concomitant anticoagulants: monitor coagulation parameters due to possible interaction. - Store at room temperature: keep in the original container, protect from moisture and light.

Mesalazine can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Azathioprine or 6‑mercaptopurine: heightened risk of myelosuppression. - Warfarin: potentiation of anticoagulant effect, increasing bleeding risk. - Sulfasalazine: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): possible renal impairment. - Oral contraceptives: reduced hormonal efficacy. - Diuretics: monitor renal function and electrolyte balance.